Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26277033)

Published in Psychiatry Res on July 29, 2015

Authors

Emil F Coccaro1, Royce Lee1, Elizabeth C Breen2, Michael R Irwin3

Author Affiliations

1: Clinical Neuroscience & Psychopharmacology Research Unit, Department of Psychiatry and Behavioral Neuroscience, University of Chicago, USA.
2: Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience, USA; Department of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine, USA.
3: Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience, USA; Department of Psychiatry and Biobehavioral Sciences, UCLA David Geffen School of Medicine, USA; Department of Psychology, UCLA, USA.

Articles cited by this

Factor structure of the Barratt impulsiveness scale. J Clin Psychol (1995) 19.86

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40

Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry (1982) 7.37

The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15

Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry (2003) 2.13

Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry (1992) 1.87

Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res (1997) 1.76

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry (1997) 1.59

Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun (2008) 1.35

Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry Clin Neurosci (1991) 1.33

C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med (2004) 1.27

The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun (2006) 1.12

Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease. Clin Pharmacol Ther (2009) 1.09

Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology (2003) 1.05

A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry (2009) 1.04

Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav (2012) 1.00

Cognitive Behavioral Therapy and Tai Chi Reverse Cellular and Genomic Markers of Inflammation in Late-Life Insomnia: A Randomized Controlled Trial. Biol Psychiatry (2015) 0.99

Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Altern Ther Health Med (2007) 0.95

Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res (2005) 0.94

Inhibitory effects of SSRIs on IFN-γ induced microglial activation through the regulation of intracellular calcium. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.93

Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry (2014) 0.93

Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study. J Clin Psychiatry (2010) 0.92

Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav Immun (2007) 0.88

Life history of impulsive behavior: development and validation of a new questionnaire. J Psychiatr Res (2011) 0.86

Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder. Psychiatr Genet (2010) 0.84

Personality disorder--not otherwise specified evidence of validity and consideration for DSM-5. Compr Psychiatry (2012) 0.81

Biological role of interleukin-1beta in defensive-aggressive behaviour. J Biol Regul Homeost Agents (2011) 0.80

A novel approach to assess inter-rater reliability in the use of the Overt Aggression Scale-Modified. Psychiatry Res (2002) 0.78